Blood‐based detection of lung cancer using cysteine‐rich angiogenic inducer 61 (CYR61) as a circulating protein biomarker: a pilot study-Reference-Cited by-同舟云学术

Blood‐based detection of lung cancer using cysteine‐rich angiogenic inducer 61 (CYR61) as a circulating protein biomarker: a pilot study

Published:2021-10-03 Issue:11 Volume:15 Page:2877-2890
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Mol Oncol

Author:

Ac\̌kar Lucija¹^ORCID,Casjens Swaantje²,Andreas Antje¹,Raiko Irina²,Brüning Thomas²,Geffken Maria³,Peine Sven³,Kollmeier Jens⁴,Johnen Georg²,Bartkowiak Kai¹,Weber Daniel Gilbert²,Pantel Klaus¹

Affiliation:

1. Department of Tumor Biology University Medical Center Hamburg‐Eppendorf Germany

2. Institute for Prevention and Occupational Medicine of the German Social Accident Insurance Institute of the Ruhr University Bochum (IPA) Germany

3. Department of Transfusion Medicine University Medical Center Hamburg‐Eppendorf Germany

4. Lungenklinik Heckeshorn Helios Klinikum Emil von Behring Berlin Germany

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.13099

Reference62 articles.

1. WHO(2020)Report on Cancer Deaths.https://www.who.int/news‐room/fact‐sheets/detail/cancer. Accessed on 22nd of September 2021.

2. Genomic alterations of plasma cell-free DNAs in small cell lung cancer and their clinical relevance

3. Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy

4. Validation of the SHOX2 / PTGER4 DNA Methylation Marker Panel for Plasma-Based Discrimination between Patients with Malignant and Nonmalignant Lung Disease

5. Lung cancer LDCT screening and mortality reduction — evidence, pitfalls and future perspectives

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Conducting polymer composite-based biosensing materials for the diagnosis of lung cancer: A review;International Journal of Biological Macromolecules;2023-12

2. CCN proteins: opportunities for clinical studies—a personal perspective;Journal of Cell Communication and Signaling;2023-05-17

3. Blood protein biomarkers in lung cancer;Cancer Letters;2022-12

4. Serum CYR61 as a potential biomarker to improve breast cancer diagnostics;Biomarkers in Medicine;2022-10

5. Effect of Statins on Lung Cancer Molecular Pathways: A Possible Therapeutic Role;Pharmaceuticals;2022-05-10